These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 33021168)
1. Facilitating Access to a COVID-19 Vaccine through Global Health Law. Gostin LO; Karim SA; Mason Meier B J Law Med Ethics; 2020 Sep; 48(3):622-626. PubMed ID: 33021168 [No Abstract] [Full Text] [Related]
2. Ensuring global access to COVID-19 vaccines. Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778 [No Abstract] [Full Text] [Related]
3. Protect against market exclusivity in the fight against COVID-19. 't Hoen E Nat Med; 2020 Jun; 26(6):813. PubMed ID: 32382151 [No Abstract] [Full Text] [Related]
4. Riding the coronacoaster of uncertainty. The Lancet Infectious Diseases Lancet Infect Dis; 2020 Jun; 20(6):629. PubMed ID: 32422202 [No Abstract] [Full Text] [Related]
5. Audio Interview: Covid-19 in Europe and New Information on Vaccines. Rubin EJ; Baden LR; Haug CJ; Morrissey S N Engl J Med; 2020 Nov; 383(21):e134. PubMed ID: 33207102 [No Abstract] [Full Text] [Related]
6. Has Global Health Law Risen to Meet the COVID-19 Challenge? Revisiting the International Health Regulations to Prepare for Future Threats. Gostin LO; Habibi R; Meier BM J Law Med Ethics; 2020 Jun; 48(2):376-381. PubMed ID: 32631189 [No Abstract] [Full Text] [Related]
7. All roads lead to coronavirus. Abbasi K J R Soc Med; 2020 Mar; 113(3):91. PubMed ID: 32160122 [No Abstract] [Full Text] [Related]
9. Keeping track of the SARS-CoV-2 vaccine pipeline. Parker EPK; Shrotri M; Kampmann B Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290 [TBL] [Abstract][Full Text] [Related]
10. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic. Abu-Raya B; Gantt S; Sadarangani M CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869 [No Abstract] [Full Text] [Related]
11. Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines. Forman R; Anderson M; Jit M; Mossialos E Vaccine; 2020 Sep; 38(39):6075-6077. PubMed ID: 32773244 [TBL] [Abstract][Full Text] [Related]
12. Prisons are "in no way equipped" to deal with COVID-19. Burki T Lancet; 2020 May; 395(10234):1411-1412. PubMed ID: 32359457 [No Abstract] [Full Text] [Related]
13. The Dual Epidemics of COVID-19 and Influenza: Vaccine Acceptance, Coverage, and Mandates. Gostin LO; Salmon DA JAMA; 2020 Jul; 324(4):335-336. PubMed ID: 32525519 [No Abstract] [Full Text] [Related]
15. Are asylum seekers, refugees and foreign migrants considered in the COVID-19 vaccine discourse? Mukumbang FC BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33177039 [No Abstract] [Full Text] [Related]
16. The Race to Develop a COVID-19 Vaccine. Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132 [TBL] [Abstract][Full Text] [Related]